Darkside of Medicine

The Medicines and Healthcare products Regulatory Agency (MHRA) is the UK government agency responsible for ensuring that medicines, medical devices, and healthcare products are safe, effective, and of appropriate quality. Its role is to protect public health by regulating medicines and monitoring their safety throughout their use.

The MHRA works to improve patient safety through a range of initiatives focused on medicine regulation, prescribing safety, adverse reaction reporting, and public awareness. One of its best-known safety initiatives is the Yellow Card Scheme, which allows healthcare professionals, patients, and carers to report suspected side effects or safety concerns relating to medicines and medical devices. These reports help identify emerging safety issues and support ongoing monitoring after medicines are licensed.

​

The MHRA has also introduced important measures to improve awareness of medicine risks during pregnancy, including strengthened warnings, educational materials, patient information leaflets, and prescribing guidance for medicines known to carry teratogenic risks. These initiatives aim to support informed decision-making, encourage shared discussions between patients and healthcare professionals, and reduce avoidable harm.

In addition to medicine safety monitoring, the MHRA contributes to:

​

• improving prescribing safety

• reducing medication errors

• strengthening pharmacovigilance systems

• monitoring medicine interactions and adverse effects

• supporting safer use of medicines in children and vulnerable groups

• increasing transparency and patient involvement in healthcare safety

• ​

The agency also works alongside organisations such as NICE, the National Health Service, and healthcare professionals to provide guidance, safety alerts, and educational resources designed to improve medicine safety across the UK.